Drug interactions
Fingolimod + Lisocabtagene maraleucel
Severity: Major
Fingolimod and Lisocabtagene maraleucel: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Fingolimod traps lymphocytes in lymph nodes and lowers circulating lymphocyte counts. This may impair collection, expansion and persistence of CAR T cells and adds to infection risk in patients already immunocompromised by lymphodepletion and CAR T therapy.
What this interaction means in plain words
Fingolimod and Lisocabtagene maraleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Fingolimod belongs to Central Nervous System; Lisocabtagene maraleucel belongs to Oncology.
Why it happens
Fingolimod sequesters lymphocytes via S1P receptor modulation, which may reduce T-cell function and number and adds to immunosuppression.
What to do
Avoid fingolimod around leukapheresis and CAR T infusion where possible, and choose a non-immunosuppressive alternative for the underlying condition. If it cannot be stopped, monitor lymphocyte counts and closely watch for infections.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Fingolimod and Lisocabtagene maraleucel, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Fingolimod
- Adenovirus types 4 and 7 live + Fingolimod Contraindicated
- Bcg vaccine live + Fingolimod Contraindicated
- Fingolimod + Pimozide Contraindicated
- Fingolimod + Ponesimod Contraindicated
- Fingolimod + Quinidine Contraindicated
- Fingolimod + Siponimod Contraindicated
Other interactions of Lisocabtagene maraleucel
Frequently asked questions
Can I take Fingolimod with Lisocabtagene maraleucel?
MediHelp rates the interaction as major. Fingolimod and Lisocabtagene maraleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Fingolimod traps lymphocytes in lymph nodes and lowers circulating lymphocyte counts. This may impair collection, expansion and persistence of CAR T cells and adds to infection risk in patients already immunocompromised by lymphodepletion and CAR T therapy.
How serious is the interaction between Fingolimod and Lisocabtagene maraleucel?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid fingolimod around leukapheresis and CAR T infusion where possible, and choose a non-immunosuppressive alternative for the underlying condition. If it cannot be stopped, monitor lymphocyte counts and closely watch for infections.
What other medicines interact with Fingolimod?
MediHelp also lists interactions of Fingolimod with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Pimozide. The full list is on the Fingolimod page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
